Cutter & CO Brokerage, Inc. Genmab A/S Transaction History

Cutter & CO Brokerage, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$31.52 - $373.61 $83,528 - $990,066	-2,650 Reduced 2.21%	117,306 $3.77 Million
Q2 2022 Jul 28, 2022	BUY	$26.83 - $38.57 $7,378 - $10,606	275 Added 0.23%	119,956 $3.9 Million
Q1 2022 May 03, 2022	BUY	$30.95 - $39.68 $5,756 - $7,380	186 Added 0.16%	119,681 $4.33 Million
Q4 2021 Feb 10, 2022	SELL	$35.87 - $47.12 $76,761 - $100,836	-2,140 Reduced 1.76%	119,495 $4.73 Million
Q3 2021 Nov 02, 2021	SELL	$41.55 - $48.72 $746,861 - $875,742	-17,975 Reduced 12.88%	121,635 $5.32 Million
Q2 2021 Aug 09, 2021	SELL	$32.88 - $44.57 $93,708 - $127,024	-2,850 Reduced 2.0%	139,610 $5.7 Million
Q1 2021 May 11, 2021	BUY	$30.92 - $44.4 $627,985 - $901,764	20,310 Added 16.63%	142,460 $4.68 Million
Q4 2020 Feb 03, 2021	SELL	$33.66 - $40.76 $117,809 - $142,660	-3,500 Reduced 2.79%	122,150 $4.97 Million
Q3 2020 Nov 05, 2020	SELL	$33.07 - $38.68 $220,742 - $258,189	-6,675 Reduced 5.04%	125,650 $4.6 Million
Q2 2020 Aug 10, 2020	SELL	$20.05 - $33.89 $265,662 - $449,042	-13,250 Reduced 9.1%	132,325 $4.48 Million
Q1 2020 May 05, 2020	SELL	$17.15 - $25.22 $81,033 - $119,164	-4,725 Reduced 3.14%	145,575 $3.09 Million
Q4 2019 Feb 11, 2020	SELL	$18.88 - $24.14 $88,736 - $113,458	-4,700 Reduced 3.03%	150,300 $3.36 Million
Q3 2019 Nov 07, 2019	BUY	$18.0 - $21.38 $2.79 Million - $3.31 Million	155,000 New	155,000 $3.14 Million

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.